AbbVie Reports First-Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
AbbVie (ABBV) Tops Q1 EPS by 2c, Revenue Misses, Offers FY Guidance
April 29, 2022 7:45 AM EDTAbbVie (NYSE: ABBV) reported Q1 EPS of $3.16, $0.02 better than the analyst estimate of $3.14. Revenue for the quarter came in at $13.54 billion versus the consensus estimate of $13.63 billion.
GUIDANCE:
AbbVie sees FY2022 EPS of $13.92-$14.12, versus the consensus of... More
